StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Morgan Stanley Downgrades AstraZeneca (AZN) to Equalweight
July 28, 2017 7:55 AM
Morgan Stanley downgraded AstraZeneca (NYSE: AZN) from Overweight to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Put Buying in AstraZeneca (AZN) Suggests Near-Term Bearish Bias in Shares -Susquehanna
July 31, 2017 3:05 PM